Dr. Ralf Piotrowiak

Angestellt, Scientist, Technologyscouting & Innovation, ZEPAI Center for Pandemic Vaccines and Therapeutics, Federal Ministry of Health

Bad Oeynhausen, Deutschland

Über mich

I have worked for BAYER Animal Health in the Science Intelligence and Technology Scouting field for over 5 years, where I established a database of potential partners and conducted numerous technology analyses. Since February 2022, I have been exclusively dedicated to serving as a technology scout for the Center for Pandemic Vaccines and Therapeutics (CEPAI) at the Paul-Ehrlich Institute, an agency under the German Federal Ministry of Health. At CEPAI, I established the Technology Scouting department for pandemic preparedness, created a database of potential partners, and globally documented and assessed new technologies relevant for vaccines, therapeutics, and diagnostics in the event of a new pandemic. A technology roadmap for innovations was developed and in-depth analyses of relevant new technologies, such as self-amplifying RNA platforms, were conducted. My contract at CEPAI is scheduled to end in May 2024. I prefer to work remotely as freelancer.

Fähigkeiten und Kenntnisse

Business Development
Management Technologieunternehmen
Lizenzabschlüsse
Finanzierung Technologieunternehmen
R&D Management
umfangreiche Erfahrungen mit Patentklagen
Drug Delivery Systems
Anti-Counterfeiting Technologies
Competitive Intelligence
Technology Scouting

Werdegang

Berufserfahrung von Ralf Piotrowiak

  • Bis heute 2 Jahre und 5 Monate, seit Feb. 2022

    Scientist, Technologyscouting & Innovation

    ZEPAI Center for Pandemic Vaccines and Therapeutics, Federal Ministry of Health

    Search and evaluation of innovative technologies in the area of pandemic vaccines and therapeutics. Establishment of a comprehensive technology scouting system and a technology roadmap in this area. Development of strategies for pandemic therapeutics and vaccines. International in-depth analysis of technology fields, including universities, startups, and biopharmaceutical companies. Networking in the area of pandemic vaccines and therapeutics.

  • Bis heute 26 Jahre und 2 Monate, seit Mai 1998

    Inhaber

    Dr. Piotrowiak Life Science Industry Consulting

    Inhaber Unternehmensberatung im Life Science Bereich

  • 1998 - 2010

    CEO & President

    MIKA Pharma GmbH

    Gesellschafter-Geschäftsführer

  • 1998 - 2007

    General Manager

    HEALTHCARE NRW e.V.

    Geschäftsführer

  • 1990 - 1998

    Geschäftsführer

    CT BIOMED Unternehmensgruppe

    Geschäftsführer

  • 1986 - 1990

    Projektmanager / Laborleiter

    QIAGEN

    product development, R&D and lab manager, establishment of an intl. sales and distribution system

  • 1984 - 1986

    Wissenschaftlicher Mitarbeiter

    Max-Planck Gesellschaft

Ausbildung von Ralf Piotrowiak

  • 1982 - 1985

    Molekulargenetik

    Max-Planck Institut für Züchtungsforschung

    Springende Gene, transposable elements, genetic engineering, molecular biology

  • 1979 - 1982

    Biologie (Diplom), Philosophie

    Universität Bochum

    Molekulargenetik

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Französisch

    Grundlagen

Interessen

paragliding
zen
arts
motorbike
saxophone

21 Mio. XING Mitglieder, von A bis Z